Chad Morin
Compliance Officer at KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC
Profile
Chad Morin is currently the Chief Compliance Officer & Vice President at Kiniksa Pharmaceuticals Ltd.
He previously worked as the Head-Compliance at ARIAD Pharmaceuticals, Inc. and as the Chief Compliance Officer & Vice President at bluebird bio, Inc. Mr. Morin completed his undergraduate degree at F.W.
Olin Graduate School of Business.
Chad Morin active positions
| Companies | Position | Start |
|---|---|---|
| KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC | Compliance Officer | 2020-09-30 |
Former positions of Chad Morin
| Companies | Position | End |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Compliance Officer | - |
| BLUEBIRD BIO, INC. | Compliance Officer | - |
Training of Chad Morin
| F.W. Olin Graduate School of Business | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Kiniksa Pharmaceuticals Ltd.
 Kiniksa Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Kiniksa Pharmaceuticals International Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Its products include Rilonacept, Mavrilimumab, Vixarelimab, and KPL-404. The company was founded by Sanj K. Patel, Stephen Frank Mahoney, Krisha S. Mahoney, Thomas W. Beetham, Christopher Heberlig, Carsten Boess, Rasmus Holm-Jorgensen, Gregory Alex Grabowksi, Aaron Isadore Young, Eben P. Tessari, Jennifer Lynne Mason and Mickenzie Elizabeth Gallagher in July 2015 and is headquartered in Lexington, MA. | Health Technology |
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology ARIAD Pharmaceuticals, Inc. operates as an oncology company, which engages in the discovery, development, and commercialization of small-molecule drugs for the treatment of cancer. The company was founded by Harvey J. Berger and James E. Rothman on January 8, 1992 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Chad Morin
